Skip to content

Osteopathic Manipulative Treatment Efficacy in Postoperative Pain

Osteopathic Manipulative Treatment Efficacy in Sternal Pain Management After Heart Surgery

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02694991
Enrollment
80
Registered
2016-03-01
Start date
2013-09-30
Completion date
2016-02-29
Last updated
2016-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain, Surgery

Keywords

surgery, outcome, pain, osteopathic manipulative treatment

Brief summary

Effectively controlling sternal pain during cardiac rehabilitation after heart surgery is very important as it reduces the risk of postoperative complications. However, the contraindications and side effects of analgesic drugs may induce physicians to use them so cautiously that pain may actually be under-treated. The aim of this open label, controlled study is to assess whether osteopathic manipulative treatment (OMT) can contribute to pain relief and improve rehabilitation outcomes.

Detailed description

The currently predominant means of controlling postoperative pain is the peri-operative administration of opioid or non-opioid (acetaminophen) analgesics, alone or in combination, and non-steroidal anti-inflammatory drugs (NSAIDs). However, anti-inflammatory drugs are contraindicated for many patients because they may impair renal function, interact with platelet aggregation, and increase the risk of gastrointestinal damage and bleeding. The spectrum of available options is narrow. Osteopathic manipulative Treatment (OMT) intervenes in the process that transforms nociceptive information into the subjective experience and it may be useful. It has been found to be effective in controlling pain after abdominal surgery, it has a beneficial effect on patients recovering coronary artery by-pass surgery and also improves cardiac function The aim of this study was to assess whether complementary OMT is an effective means of reducing post-surgical sternal pain and improving rib cage mobility after heart surgery involving sternotomy, and to investigate its advantages during in-patient rehabilitation in terms of functional recovery, and perceived anxiety and depression. This open, randomised, semi-blinded, controlled trial involves inclusion of 80 adult patients of both genders consecutively admitted as in-patients to cardiac rehabilitation unit after undergoing elective coronary artery by-pass grafting (CABG), valve replacement or repair and/or ascending aorta surgery with sternotomy, and capable of voluntarily providing their written informed consent. The patients are divided in 2 groups, the intervention group receiving OMT and the control group. Both groups are following the same rehabilitation programme and receiving usual care. All of the subjects taking part in the study are receiving standard care in accordance with the international guidelines for in-patient cardiac rehabilitation; the only experimental intervention is the addition of OMT

Interventions

OTHEROsteopathic Manipulative Treatment

The thoracic wall is gently manipulated in conscious subjects in a supine position in order to facilitate greater diaphragmatic excursion. The thorax is palpated by applying a low pressure load directly on the skin in the direction of resistance, without any sliding over the skin or forcing of the subcutaneous tissue until it begins to yield and there is a sensation of softening. Sterile procedures are used when touching the patients near the surgical site. The treatment consists of a fixed and preordained sequence of three sessions, beginning with the costal arch on the diaphragm and then moving to the sternal area and, finally, the region of the thoracic outlet. The first two phases are performed from the right side, and the third from the head of the bed.

Sponsors

Fondazione Don Carlo Gnocchi Onlus
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Recent artery bypass grafting (CABG) * Recent valve replacement or repair * Recent ascending aorta surgery

Exclusion criteria

* Heart surgery using mini-thoracotomy. * Heart transplantation * Implant of a ventricular assistance device * Diabetes mellitus * Rheumatoid arthritis * Autoimmune diseases * Altered cognitive capacities

Design outcomes

Primary

MeasureTime frameDescription
Pain intensity relief21 daysPain intensity measured with visual analogic scale (VAS)

Secondary

MeasureTime frameDescription
Functional capacity improvement21 daysDistance in meters walked in six minutes
Respiratory function21 daysInspiratory volume variation measured as mL of air inspired
Hospitalization length21 daysNumber of days of hospitalisation
Anxiety and Depression21 daysHospital Anxiety and Depression Scale (HADS) score
Analgesic drug consumption.21 daysNumber of analgesic drug doses taken

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026